Search

everythinglearnresearchcommunity

for

Search:↓

Two women were diagnosed with a rare melanoma that looked like hair loss but was actually a type of skin cancer.

Most hair loss in children is caused by a few common conditions and is easy to diagnose, but rare types require careful evaluation.

Combining intradermotherapy with microneedling and a topical solution reduces hair loss more effectively than intradermotherapy alone.

Blood vessel patterns in skin diseases relate to certain blood markers in systemic sclerosis but not in psoriasis or psoriatic arthritis, and may indicate circulation issues in alopecia.

People with alopecia areata often have lower levels of vitamin D, zinc, and folate, but more research is needed to understand if supplements can help treat it.

New alopecia treatments aim for better results and fewer side effects.

The model suggests that scalp tension could lead to hair loss, with factors like blood vessel hardening, enlarged oil glands, and poor microcirculation also playing a role. It also hints at a possible link between skull shape and baldness pattern.

Minoxidil and finasteride can help with hair loss, but more research is needed to improve treatments for certain types of hair loss.

Dutasteride works better than finasteride for hair loss, with both being safe to use.

Tofacitinib, a medication for arthritis, showed potential for treating severe hair loss in a small Brazilian case series, but more research is needed.

Balding and low testosterone increase risk of urinary stones.

In 2017, Spanish dermatologists commonly prescribed topical minoxidil, oral finasteride, and nutricosmetics for hair loss, with oral contraceptives also used for premenopausal women. Less common were oral dutasteride, due to side effects, and newer, more expensive treatments like topical finasteride and Low-Level Laser Therapy. The conclusion is that there's a need for prescription guidelines due to varied treatment approaches.

JAK inhibitors, like baricitinib, are effective and safe for treating alopecia areata.

Early balding, premature graying, and hair thinning can predict heart disease in young Asian males.

Only minoxidil and finasteride are FDA-approved for hair loss, with other treatments available but less effective or with side effects.

Hair loss linked to kidney stones in people under 60.

Stopping infliximab and using strong topical steroids can regrow hair lost due to psoriasiform alopecia.

Alopecia Areata is an unpredictable autoimmune hair loss condition with limited and variable treatment effectiveness.

Tofacitinib is effective and safe for severe hair loss, but full regrowth is less likely after 10 years of hair loss.

Tofacitinib is safe and effective for severe alopecia areata, but hair loss may return 2 months after stopping treatment.

Ruxolitinib effectively regrows hair in most patients with severe hair loss.

Some treatments can help with a hair loss condition called alopecia areata, but none ensure lasting results; choices depend on the person, with JAK inhibitors showing promise for severe cases.

New treatments for Alopecia Areata show promise but need to be more effective and affordable.

Both vitiligo and alopecia areata involve an immune response triggered by stress and specific genes, with treatments targeting this pathway showing potential.

A patient with alopecia areata regrew hair after taking tofacitinib and showed changes in certain blood and skin markers.

Baricitinib is effective and safe for treating severe alopecia areata.

Both ruxolitinib and tofacitinib are effective and safe for treating severe alopecia areata, but relapses are common.

Tofacitinib is somewhat effective for alopecia areata, but more research is needed on its safety and long-term effects.

Apremilast was not effective in treating moderate-to-severe alopecia areata.

Topical tofacitinib may grow hair better than minoxidil by increasing VEGF and reducing inflammation.